HER2 Heterogeneity in Gastric Cancer: A Comparative Study, Using Two Commercial Antibodies

BACKGROUND: Although amplification of the gene encoding human epidermal growth factor receptor 2 (HER2) is used as an indicator for response to trastuzumab, the reported response rate is low, and few patients with gastric cancer (GC) benefit from this individualized therapy. The aim of this study wa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Oncol
Hlavní autoři: Satala, Catalin Bogdan, Jung, Ioan, Stefan-van Staden, Raluca Ioana, Kovacs, Zsolt, Molnar, Calin, Bara, Tivadar, Fulop, Zsolt Zoltan, Gurzu, Simona
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7596543/
https://ncbi.nlm.nih.gov/pubmed/33144857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8860174
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky